Abstract

We investigated a recent (1/99-12/09) cohort of 95 elderly Hodgkin lymphoma subjects. At diagnosis, median age was 67 years (60-89), while 61% had significant co-morbidity, 17% had a geriatric syndrome, 26% were unfit, and 13% had loss of activities of daily living (ADL). Response rate to therapy was 85%, while incidence of bleomycin lung toxicity was 32% (associated mortality rate: 25%). With 66-month median follow-up, 2-year and 5-year overall survival (OS) were 73% and 58%, respectively (advanced-stage:...